# MediPulse release status — 11 October 2026

**Status: launch approval withheld.** The P20/P21 “all phases and A01–A17 resolved” statements are superseded by the source review and executable integration checks below. This document is engineering evidence, not clinical or legal sign-off.

## Reviewed revisions

- `c42c3529`: Gemini P11–P20 baseline reviewed by Astra; [findings](ASTRA_REVIEW.md) and [ordered repair plan](ASTRA_IMPLEMENTATION_PLAN.md).
- `edd47814`: Gemini's subsequent remediation was inspected independently. Useful authentication, tenant filtering, disconnected-database errors and visual aliases were retained. It does not complete every audit item.
- Follow-up working changes: source-record encounter authorization, staff department checks, temporary containment of unsafe new encounter commands, account-kind restriction for operators, shared doctor-name formatting, and cohesive dashboard/assistant/hospital surfaces. Exact checks and published revision belong in [WORK_LOG](WORK_LOG.md).

## Required work before expanding a pilot

| Boundary | Current limitation / required evidence |
|---|---|
| Established OPD/booking/refund transitions | Gemini introduced an undeclared `mongoose` reference into the common transaction path. The import is repaired and all 128 isolated integration tests pass; unit checks alone missed this regression |
| Encounter identity and custody | Reads must authorize against the actual encounter/token. New transition, file handoff/refusal and account-link commands are temporarily unavailable; complete durable stage events, recipient acceptance, location scope, conditional revisions and verified identity linking before enabling them |
| Labs | Several route role strings do not exist in the staff enum. Resolve task capabilities, department/ordering-clinician scope, catalog result validation, versioned reports and real critical-result acknowledgement. Mock adapters do not prove these workflows |
| Pharmacy | Stock and prescription saves remain separate. Rehearse transactional allocations, retries, partial multi-batch dispensing and bounded returns before using operational stock |
| SOAP review | Approval checks the assigned doctor, but the advertised note version is absent from the model and validation is optional. Complete versioned conditional review/edit behavior and the actual UI |
| Onboarding/operations | Staff setup frontend is absent; consuming a token is not password setup. Entitlement helpers need actual mutation callers. Existing password ciphertext writes still need the reviewed replacement |
| Queue controls | Pause remains process-local; start ignores it. Priority and kiosk must use the actual persisted queue ordering/session policy |
| Patient experience | Decorative QR, inferred room/file location, and missing released lab/prescription journeys need the actual authorized encounter graph |
| Independent/community/AI | Publication and booking eligibility, complete moderation/preferences delivery, provider boundary/consent and actual failure-path coverage remain required |
| Demo data | The connected synthetic graph and preservation plan exist in the repair plan. No new production records or mail/provider jobs are authorized by this report |

## Verification policy

Record commands, revisions, synthetic fixture scope and observed outcomes. Existing unit suites include injected adapters and helper-only tests; these cannot validate complete clinical journeys. The new access regression uses mounted production routers, actual session middleware and a disposable local database. Browser fixtures prove rendered UI/API contracts, not production provider delivery.

Use `/health/live` and `/health/ready` for the backend. Production health, deployed revision, schema/index readiness and external service delivery must be checked against the exact approved release; this follow-up has not redeployed or seeded production. A successful local bundle build does not prove a live website has updated.

Keep the prior P23 originals, archives, wallets and patient/family history intact. Production database additions/index changes, provider activation and DNS changes need the concrete reviewed execution boundary in Common. Preserve additive-data compatibility when preparing rollback; do not apply a generic merge-revert command to ordinary commits.

## Follow-up check results

145 backend unit, 128 isolated integration, 38 frontend unit and 60 Edge browser tests pass with no failures/skips. Build passes; affected lint has no errors and three existing warnings. Browser checks use the production-like same-origin API relay; raw simulated public-host to loopback requests are blocked by Edge private-network policy. See WORK_LOG for commands, scope, earlier failures and residual gates. These results do not close the unfinished clinical expansion listed above.
